Anavex Life Sciences Corp. (AVXL)
4.07
+0.15
(+3.83%)
USD |
NASDAQ |
Feb 13, 14:14
Anavex Life Sciences Free Cash Flow : -34.08M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CorMedix, Inc. | 74.42M |
| Verastem, Inc. | -140.93M |
| Ocugen, Inc. | -53.53M |
| AnaptysBio, Inc. | -145.42M |
| Replimune Group, Inc. | -283.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.151M |
| Cash from Financing (Quarterly) | 36.32M |
| Free Cash Flow Per Share (Quarterly) | -0.0803 |
| Free Cash Flow to Equity (Quarterly) | -7.151M |
| Free Cash Flow to Firm (Quarterly) | -7.151M |
| Free Cash Flow Yield | -9.70% |